Skip to main content

Advertisement

Log in

President’s message: Ensuring appropriate ordering of tests and eliminating inconclusive test results

  • Journal of Nuclear Cardiology News Update
  • Asnc News
  • Published:
Journal of Nuclear Cardiology Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. O’Keefe JH, Bateman TH, Barnhart CS. Adenosine thallium-201 is superior to exercise thallium-201 for detecting coronary artery disease in patients with left bundle branch block. J Am Coll Cardiol 1993;21:1332–8.

    Article  PubMed  Google Scholar 

  2. Lakkis NM, He Z-X, Verani MS. Diagnosis of coronary artery disease by exercise thallium-201 tomography in patients with a right ventricular pacemaker. J Am Coll Cardiol 1997;29:1221–5.

    Article  PubMed  CAS  Google Scholar 

  3. Sharir T, Rabinowitz B, Livschitz S, Moalem I, Baron J, Kaplinsky E, et al. Underestimation of extent and severity of coronary artery disease by dipyridamole stress thallium-201 single-photon emission computed tomographic myocardial perfusion imaging in patients taking antianginal drugs. J Am Coll Cardiol 1998;31:1540–6.

    Article  PubMed  CAS  Google Scholar 

  4. Taillefer R, Ahlberg AW, Masood Y, White CM, Lamargese L, Mather JF, et al. Acute beta-blockade reduces the extent and severity of myocardial perfusion defects with dipyridamole Tc-99m sestamibi SPECT imaging. J Am Coll Cardiol 2003;42:1475–83.

    Article  PubMed  CAS  Google Scholar 

  5. Calnon DA, Glover DK, Beller GA, Vanzetto G, Smith WH, Watson DD, et al. Effects of dobutamine stress on myocardial blood flow, 99mTc sestamibi uptake, and systolic wall thickening in the presence of coronary artery stenoses. Implications for dobutamine stress testing. Circulation 1997;96:2353–60.

    PubMed  CAS  Google Scholar 

  6. Wu JC, Yun JJ, Heller EN, Dione DP, DeMan P, Liu YH, et al. Limitations of dobutamine for enhancing flow heterogeneity in the presence of single coronary stenosis: implications for technetium- 99m-sestamibi imaging. J Nucl Med 1998;39:417–25.

    PubMed  CAS  Google Scholar 

  7. Elhendy A, Sozzi FB, Valkema R, van Domburg RT, Bax JJ, Roelandt JRTC. Dobutamine technetium-99m tetrofosmin SPECT imaging for the diagnosis of coronary artery disease in patients with limited exercise capacity. J Nucl Cardiol 2000;7:649–54.

    Article  PubMed  CAS  Google Scholar 

  8. Navare SM, Katten D, Johnson LL, Mather JF, Fowler MS, Ahlberg AW, et al. Risk stratification with electrocardiographic-gated dobutamine stress technetium-99m sestamibi single-photon emission tomographic imaging: value of heart rate response and assessment of left ventricular function. J Am Coll Cardiol 2006;47:781–8.

    Article  PubMed  Google Scholar 

  9. Geleijnse ML, Elhendy A, Fioretti PM, Roelandt JRTC. Dobutamine stress myocardial perfusion imaging. J Am Coll Cardiol 2000;36:2017–27.

    Article  PubMed  CAS  Google Scholar 

  10. Brindis RG, Douglas PS, Hendel RC, Peterson ED, Wolk MJ, Allen JM, et al. ACCF/ASNC appropriateness criteria for singlephoton emission computed tomography myocardial perfusion imaging (SPECT MPI). A report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology. J Am Coll Cardiol 2005;46:1587–605.

    Article  PubMed  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gerson, M.C. President’s message: Ensuring appropriate ordering of tests and eliminating inconclusive test results. J Nucl Cardiol 13, 593–594 (2006). https://doi.org/10.1016/j.nuclcard.2006.05.010

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.nuclcard.2006.05.010

Navigation